Angela Zhou

Manager of Scientific Analysis and Insights, CAS

Bio

Angela Zhou serves as the Executive Editor of CAS Insights and the Lead Scientist in Life Sciences at CAS. Dr. Zhou earned her Ph.D. in Molecular Pharmacology and Toxicology from the University of Southern California, followed by postdoctoral training in cell biology at Johns Hopkins School of Medicine and specialized research in cancer therapeutics at Harvard Medical School.

Prior to joining CAS, Dr. Zhou held faculty positions at Missouri State University and Denison University, concentrating on teaching and research of cancer biology, cell signaling and biochemistry. At CAS, she leads a multidisciplinary team of research and data scientists who leverage comprehensive scientific databases. Dr. Zhou's unique blend of scientific expertise and data analytics leadership enables her team to deliver strategic intelligence, helping organizations navigate emerging trends and opportunities across chemistry, life sciences, and materials science.

__wf_예약_상속
생명공학

Extremophiles: Unlocking biomedical and industrial innovations from life at the edge

Extremophiles are microorganisms that survive in Earth’s harshest environments. Find out how their unique capabilities are changing biomedicine, environmental clean-ups, and more.
|인사이트 보고서
__wf_예약_상속
생명공학

Molecular de-extinction opens possibilities for new antibiotics

Molecular de-extinction revives genes and proteins from ancient sources, and it may hold the key to new antibiotics that fight drug-resistant pathogens.
|기사
__wf_예약_상속
이머징 사이언스

지질 기반 약물 전달의 미래.

지질 기반 약물 전달 환경 웨비나 요약
|웹 세미나
__wf_예약_상속
이머징 사이언스

Friend, not foe: Harnessing the gut microbiome for health benefits

The gut microbiome is a complex ecosystem of trillions of bacteria that live in our digestive tracts with health benefits like immunity, improved mental health, and therapeutic options.
|기사
__wf_예약_상속
약물 발견

ACE2: 질병 발병에 있어 잠재적으로 중요한 수용체의 표적화

COVID-19를 비롯한 수많은 기타 바이러스 감염의 중요 표적 단백질인 ACE2에 대해 알아보십시오. 이 글은 표적 ACE2 단백질 관련 간행물, 중대 업적과 및 향후 응용 분야에 대한 통찰력과 새로운 동향 정보를 제공합니다.
|기사
__wf_예약_상속
이머징 사이언스

환각성 약물의 우울증과 PTSD 치료 효과

최근 임상 시험 결과에 따르면 복용량과 투여법을 올바르게 관리한다는 전제하에 LSD, MDMA, 실로시빈과 같은 환각성 약물로 정신 건강 장애 치료에 긍정적인 효과를 기대할 수 있는 것으로 밝혀졌습니다. 최신 연구 자료를 읽어보십시오.
|기사